Stay updated with breaking news from Channel Medsystems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(New York, USA) The Global Endometrial Ablation Devices Market was valued at USD 3,538.60 million in 2022 and growing at a CAGR of 4.95% during the
In the M&A context, “hell or high water” clauses are often negotiated where obtaining antitrust or regulatory approval is a condition precedent to closing the deal. Such provisions may ...
Cerene Cryotherapy is clinically proven to significantly reduce menstrual bleeding and premenstrual symptoms safely and effectively with high patient satisfaction through 36 months following treatmentBERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower eve...
Channel Medsystems announced today that long-term clinical outcomes support its Cerene cryotherapy for treating heavy menstrual bleeding.
Delaware courts, where the dispute between the two sides is set to be litigated, have set a high bar for acquirers being allowed to abandon their deals.